COVID-19 and Diabetes

Diabetes mellitus patients are more likely to develop coronavirus disease 2019 (COVID-19), which is caused by infection with the severe acute respiratory syndrome coronavirus 2. COVID-19 may increase the risk of hyperglycemia in infected individuals. When combined with other risk factors, hyperglycemia may modulate immunological and inflammatory responses, predisposing individuals to severe COVID-19 and potentially fatal outcomes. Patients with diabetes should be aware that COVID-19 can raise blood glucose levels, so they should follow clinical guidelines for diabetes management more closely during the treatment period as:

  • Controlling glucose levels in pandemic
  • Inflammation and diabetes
  • Immunology and diabetes
  • Diabetes after COVID-19 positive

    Related Conference of COVID-19 and Diabetes

    October 16-17, 2023

    4th Asia Pacific Congress on Diabetes and Endocrinology

    Vancouver, Canada
    October 16-17, 2023

    2nd World congress and Expo on Diabetes

    Vancouver, Canada
    October 21-22, 2023

    4th World Summit on Diabetes Expo

    New York, USA
    November 13-14, 2023

    3rd European Endocrinology and Diabetes Congress

    Paris, France
    November 16-17, 2023

    7th Annual Conference on Diabetes and Endocrinology

    Paris, France
    November 20-21, 2023

    17th European Diabetes and Endocrinology Congress

    Dubai, UAE
    November 22-23, 2023

    19th World Congress on Endocrinology & Diabetes

    Amsterdam, Netherlands
    November 27-28, 2023

    27th International Conference on Diabetes, Endocrinology and Healthcare

    Singapore City, Singapore
    January 11-12, 2024

    5th Global summit on Diabetes and Endocrinology

    Dubai, UAE
    February 19-20, 2024

    33rd European Diabetes Congress

    London, UK
    March 25-26, 2024

    5th Annual Conference on Diabetes

    London, UK

    COVID-19 and Diabetes Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in